Suchergebnisse - "Kaufman, B"

PubPharm (549)

1

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2022

von Geyer, C. | Garber, J. | Gelber, R. | +174

2

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer : original article

enthalten in: Annals of oncology | 28 November 2022

von Geyer, C. | Garber, J. | Gelber, R. | +73

3

ESO-ESMO fifth international consensus guidelines for breast cancer in young women (BCY5)

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2022

von Paluch-Shimon, S. | Cardoso, F. | Partridge, A. | +20

4

Veliparib monotherapy following carboplatin/paclitaxel plus veliparib combination therapy in patients with germline BRCA-associated advanced breast cancer : results of exploratory analyses from the phase III BROCADE3 trial

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2022

von Han, H. | Arun, B. | Kaufman, B. | +12

5

Immune checkpoint inhibitors-related encephalitis in melanoma and non-melanoma cancer patients : a single center experience

enthalten in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer | 2021

von Taliansky, A. | Furman, O. | Gadot, M. | +7

6

Final results from the PERUSE study of first-line pertuzumab plus trastuzumab plus a taxane for HER2-positive locally recurrent or metastatic breast cancer, with a multivariable approach to guide prognostication

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2021

von Miles, D. | Ciruelos, E. | Schneeweiss, A. | +116

CommentIn: Ann Oncol. 2021 Oct;32(10):1206-1208. - PMID 34403778

7

Adjuvant T-DM1 versus trastuzumab in patients with residual invasive disease after neoadjuvant therapy for HER2-positive breast cancer : subgroup analyses from KATHERINE

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2021

von Mamounas, E. | Untch, M. | Mano, M. | +27

CommentIn: Ann Oncol. 2021 Sep;32(9):1191. - PMID 34023398

8

Immune checkpoint inhibitors–related encephalitis in melanoma and non-melanoma cancer patients: a single center experience

enthalten in: Supportive care in cancer | 2021

von Taliansky, A. | Furman, O. | Gadot, M. | +7

9

Immune checkpoint inhibitors–related encephalitis in melanoma and non-melanoma cancer patients: a single center experience

enthalten in: Supportive care in cancer | 2021

von Taliansky, A. | Furman, O. | Gadot, M. | +7

10

Immune checkpoint inhibitors–related encephalitis in melanoma and non-melanoma cancer patients: a single center experience

enthalten in: Supportive care in cancer | 2021

von Taliansky, A. | Furman, O. | Gadot, M. | +7

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[55]